Alnylam Pharmaceuticals (ALNY.MX) Q2 2016 Earnings

2MayConfirmed
Q3 2015
Q4 2015
Q1 2016
Q2 2016
-20.79
-17.89
-14.99
-12.08

Details

Expected EPS
-18.5589468
Actual EPS
-20.792894099999998
Surprise EPS
-2.23
Surprise Percent
+12.04%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -20.792894099999998 per share for Q2 2016.

0 Comments

Share your thoughts